In a growing IPO market, AbSci, Vancouver, A Washington-based biotech company prepares for a public offering, joining additional Washington state biotech startups in the public including Impel Neuropharma, Sana Biotechnology, Athira Pharma, and Silverback Therapeutics.
“The amount of investment that is pouring into biotechnology and the life sciences is incredible,” said Leslie Alexandre. “Investors have really woken up and seen the opportunity.”